Endpoints News 生物医药· Ayisha Sharma·· 15 天前AI 评分51
默沙东公布 MASH 药物的肝活检数据
#AASLD26: Merck unwraps biopsy data for MASH drug it got from South Korea's Hanmi
AI 导读
默沙东公布了其双 GLP-1/glucagon 药物 MASH 在中期肝病试验中的活检数据。
正文
Merck reported Thursday its dual GLP-1/glucagon agonist cleared a mid-stage trial in the liver disease called MASH, sharing biopsy data on a drug it licensed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news